open access

Vol 15, No 1 (2019)
Case report
Published online: 2019-04-16
Get Citation

Long-term survival after surgical resection of locoregional gastric adenocarcinoma recurrence — a case report

Piotr Woźnicki, Małgorzata Malinowska, Marek Mądrecki, Tomasz Olesiński
DOI: 10.5603/OCP.2019.0006
·
Oncol Clin Pract 2019;15(1).

open access

Vol 15, No 1 (2019)
CASE REPORT
Published online: 2019-04-16

Abstract

Introduction. Recurrence is the leading cause of death of gastric cancer patients after curative resection. This report describes a 44-year-old woman with gastric adenocarcinoma and surgically resected locoregional recurrence, who has survived for more than 13 years after diagnosis.
Case report. A 33-year-old woman was admitted to the Gastroenterology Clinic with an episode of epigastric pain and minor weight loss. Two years earlier she had been diagnosed with gastric adenocarcinoma G2 of the antrum, pT2N1M0 (IIA) stage. She had undergone total gastrectomy with D2 lymphadenectomy and Roux-en-Y anastomosis followed by postoperative chemotherapy. Further diagnostic investigation after two years revealed the presence of metastatic cancer in the gastric bed. An explorative laparotomy was performed, and the surgeons successfully excised the enlarged lymph node. Post-operative pathologic examination proved gastric cancer metastasis. Since April 2007 the patient has stayed recurrence-free, and there have been no signs of recurrence on either US or CT scan, as of April 2018. This patient represents a rare case of long-term survival of recurrent gastric adenocarcinoma successfully treated with surgery despite particularly poor prognosis.
Conclusions. Surgery for gastric cancer recurrence is a valuable treatment in chosen patients, provided it is performed by a team of specialised surgeons.

Abstract

Introduction. Recurrence is the leading cause of death of gastric cancer patients after curative resection. This report describes a 44-year-old woman with gastric adenocarcinoma and surgically resected locoregional recurrence, who has survived for more than 13 years after diagnosis.
Case report. A 33-year-old woman was admitted to the Gastroenterology Clinic with an episode of epigastric pain and minor weight loss. Two years earlier she had been diagnosed with gastric adenocarcinoma G2 of the antrum, pT2N1M0 (IIA) stage. She had undergone total gastrectomy with D2 lymphadenectomy and Roux-en-Y anastomosis followed by postoperative chemotherapy. Further diagnostic investigation after two years revealed the presence of metastatic cancer in the gastric bed. An explorative laparotomy was performed, and the surgeons successfully excised the enlarged lymph node. Post-operative pathologic examination proved gastric cancer metastasis. Since April 2007 the patient has stayed recurrence-free, and there have been no signs of recurrence on either US or CT scan, as of April 2018. This patient represents a rare case of long-term survival of recurrent gastric adenocarcinoma successfully treated with surgery despite particularly poor prognosis.
Conclusions. Surgery for gastric cancer recurrence is a valuable treatment in chosen patients, provided it is performed by a team of specialised surgeons.

Get Citation

Keywords

gastric carcinoma, locoregional recurrence, surgical resection

About this article
Title

Long-term survival after surgical resection of locoregional gastric adenocarcinoma recurrence — a case report

Journal

Oncology in Clinical Practice

Issue

Vol 15, No 1 (2019)

Article type

Case report

Published online

2019-04-16

DOI

10.5603/OCP.2019.0006

Bibliographic record

Oncol Clin Pract 2019;15(1).

Keywords

gastric carcinoma
locoregional recurrence
surgical resection

Authors

Piotr Woźnicki
Małgorzata Malinowska
Marek Mądrecki
Tomasz Olesiński

References (12)
  1. In H, Ravetch E, Langdon-Embry M, et al. The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging. Gastric Cancer. 2018; 21(1): 1–9.
  2. Kong F, Qi Y, Liu H, et al. Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis. Clin Transl Oncol. 2015; 17(11): 917–924.
  3. Dicken BJ, Bigam DL, Cass C, et al. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005; 241(1): 27–39.
  4. Lehnert T, Rudek B, Buhl K, et al. Surgical therapy for loco-regional recurrence and distant metastasis of gastric cancer. Eur J Surg Oncol. 2002; 28(4): 455–461.
  5. Watanabe M, Suzuki H, Maejima K, et al. Surgical resection of late solitary locoregional gastric cancer recurrence in stomach bed. Med Sci Monit, 2012;18(7):CS53-56. DOI: 10 1016/j ijscr. 2014; 10: 005.
  6. de Liaño AD, Yarnoz C, Aguilar R, et al. Surgical treatment of recurrent gastric cancer. Gastric Cancer. 2008; 11(1): 10–14.
  7. Smyth EC, Verheij M, Allum W, et al. ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016; 27(suppl 5): v38–v49.
  8. Nunobe S, Hiki N, Ohyama S, et al. Outcome of surgical treatment for patients with locoregional recurrence of gastric cancer. Langenbecks Arch Surg. 2011; 396(2): 161–166.
  9. Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000; 87(2): 236–242.
  10. Song KY, Park SM, Kim SN, et al. The role of surgery in the treatment of recurrent gastric cancer. Am J Surg. 2008; 196(1): 19–22.
  11. Kiyasu Y. Long-term recurrence-free survival after metachronous surgery of the stomach and liver for gastric adenocarcinoma and multiple, synchronous liver metastases: a case report and review of literature. Int Surg. 2013; 98(3): 241–246.
  12. Ambiru S, Miyazaki M, Ito H, et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg. 2001; 181(3): 279–283.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl